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Abstract
PN (parenteral nutrition) should be standardised to ensure quality and
to reduce complications, and it should be carried out in consultation
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with a specialised nutrition support team whenever possible. Interdis-
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ciplinary nutrition support teams should be established in all hospitals
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4 because effectiveness and efficiency in the implementation of PN are
increased. The tasks of the team include improvements of quality of D. Schwab
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careaswellasenhancingthebenefittocostratio.Therapeuticdecisions
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must be taken by attending physicians, who should collaborate with
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the nutrition support team. “All-in-One” bags are generally preferred for
PN in hospitals and may be industrially manufactured, industrially
manufactured with the necessity to add micronutrients, or be prepared guidelines for “on-demand”withinoroutsidethehospitalaccordingtoastandardised
parenteral nutrition of orindividualcompositionandunderconsiderationofsterileandaseptic
The German conditions. A standardised procedure should be established for intro-
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indicated if the expected duration of when PN exceeds 4 weeks. Home
PNisawellestablishedmethodforprovidinglong-termPN,whichshould
beindicatedbytheattendingphysicianandbereviewedbythenutrition
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support team. The care of home PN patients should be standardised
whenever possible. The indication for home PN should be regularly re-
viewed during the course of PN.
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Zusammenfassung
Die parenterale Ernährung (PE) im Krankenhaus sollte standardisiert
werden um die Qualität zu erhöhen und die Komplikationsraten zu re-
University of Hannover,
Germany
3 Dept. of Gastroenterology,
Hepatology and Nutrition,
duzieren. PN sollte soweit möglich in Konsultation mit einem speziali- University of Basel,
Switzerland siertenErnährungsteamdurchgeführtwerden.Eininterdisziplinärarbei-
tendesErnährungsteamsollteinallenKrankenhäusernetabliertwerden,
4 PharmacyundPatientAdvice
Centre,ClinicFulda,Germany um die Effektivität und die Effizienz der Durchführung der Ernährungs-
therapie zu verbessern. Die Aufgaben des Teams sind vielseitig und
5 Dept. Medicine II, Martha-
Maria Hospital, Nuremberg,
Germany
beinhaltenu.a.dieVerbesserungderernährungsmedizinischenQualität
sowie der Wirtschaftlichkeit. Die Indikation zu medizinischen Maßnah-
men einschließlich der PE muss durch den behandelten Arzt gestellte
6 Dept. of General, Visceral,
VascularandThoraxSurgery,
werden und sollte unter Einbezug des Ernährungsteams erfolgen. „All-
in-One“-Beutel werden generell für die PE im Krankenhaus bevorzugt
HumboldtUniversityofBerlin,
Germany
und können entweder vollständig industriell hergestellt, industriell
hergestellt mit der Notwendigkeit individueller Zugaben von Mikrosub-
straten, oder innerhalb bzw. außerhalb des Krankenhauses nach
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Review Article OPEN ACCESS Special Issuestandardisierterbzw.individuellerRezeptur„ondemand“unterBerück-
sichtigungvonsterilenundaseptischenBedingungenzubereitetwerden.
Im Laufe einer PE sollte generell ein enteraler oder oraler Kostaufbau
nach standardisiertem Schema angestrebt werden. Eine Indikation für
eineHeim-PEkanngestelltwerdenwenneinePE-Dauervonmindestens
vier Wochen erwartet wird. Heim-PE ist ein medizinisch etabliertes
VerfahrenzurlangfristigenPE,diedurchdenbehandelndenArztindiziert
wirdunddurcheinErnährungsteambegleitetwerdensollte.DieBetreu-
ung des heimparenteralen Patienten sollte möglichst standardisiert
erfolgen. Die Indikation zur Heim-PE ist im Verlauf regelmäßig zu über-
prüfen.
Schlüsselwörter:Ernährungsteam,individuelleRezeptur,Compounding,
Mehrkammerbeutel, heimparenterale Ernährung
Nutrition support team
Organisation of parenteral nutrition in
hospitals
• PN in hospitals should be standardised and carried
outinconsultationwithaspecialisednutritionsupport
team whenever possible (C).
• Nutrition support teams should be established in
hospitals, because effectiveness and efficiency in the
implementation of PN are increased (A).
• The nutrition support team should work in close con-
sultation with the medical and nursing staff (C).
Commentary
The practical implementation of artificial nutrition often
does not correspond with current scientific evidence,
mainly due to a lack of specialist knowledge and insuffi-
cient organisation. This particularly applies to the inten-
sivecaresectorwherenutritionsupportisoftenrequired
[1]. Less than 5% of hospitals in Germany have estab-
lished nutrition support teams, which is a far lower rate
than in some other European countries such as the UK
[2], [3]. The impact of nutrition support teams has been
evaluatedinvariousstudies.Withnutritionsupportteams,
patients’ energy requirements are more likely to be met
and mechanical as well as metabolic complications of
nutritional therapy are reduced [4], [5], [6], [7], [8], [9].
The authors of a meta-analysis of all studies published
between 1970 and 1993 [10] concluded that nutrition
support teams reduce the rate of catheter sepsis and
metabolic complications, improve documentation, and
probably also lower costs, although the personnel costs
of the team were not taken into consideration in all
studies. The economic benefits of setting up a nutrition
support team, and even of only a dedicated nutrition
nurse, have been extensively documented [11], [12],
[13], [14]. Standardisation of product selection and of
prescribing can result in significant savings [15].
If it is not possible to establish a nutrition support team,
then at least a physician dedicated to nutrition support
should be available, with support by other staff such as
nursing staff and dieticians, wherever possible.
Establishing a nutrition support team
• A nutrition support team should be established in all
hospitals and should include physicians, nurses and
dieticians and/or nutritionists trained in clinical nutri-
tion; pharmacists, technical assistants and adminis-
trative assistants should also be available if possible
(C).
• The appropriate size of the team depends on the size
of the hospital, the scope of the hospital, the number
of patients cared for, the budget and other activities
of the team (C).
• Thetasksoftheteamincludereviewingtheindications
forPN,documentingthepatient’snutritionalstateand
metabolic situation both at the beginning and during
PN, developing and adapting the PN composition or
selecting the commercially available bags as well as
monitoring sterility, compatibility and stability of the
nutrition bag. The team should also be involved in
helping to identify when PN is no longer required, in
collaborationwiththeattendingphysician,inplanning
the introduction and advancement of enteral or oral
nutrition, and in helping organising home PN when
necessary. The team should pay particular attention
to implementing PN according to current scientific
knowledge and guidelines. The tasks of the team also
includetrainingpersonnel,patientsandtheirrelatives
(C).
Commentary
The nutrition support team should advise the ward on
the choice of standard or individual PN solutions, how
they should be prepared in individual cases, which hy-
giene and compatibility aspects must be observed, how
PN should be administered (e.g. selection of access,
tubes, pumps) and how possible complications may be
prevented(cf.chapter“Accesstechniqueanditsproblems
in parenteral nutrition” http://www.egms.de/en/
gms/2009-7/000078.shtml). The monitoring of PN
comprises laboratory, clinical and anthropometrical
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http://www.egms.de/en/gms/2009-7/000074.shtml).
The team's task is to improve the medical quality and at
the same time optimise the benefit to cost ratio of this
expensive form of nutrition. This can be achieved by
monitoringindicationandcompositionofPN,byproviding
suitable quantities and selection of substrates, as well
as suggesting alternatives as appropriate.
Indication for PN
• Therapeutic decisions, including those on using PN,
must be taken by the attending physicians. The nutri-
tion support team should be involved in decisions on
PN (C).
Commentary
Legal regulations indicate the physician’s responsibility
for decisions on PN, whereas the role of the nutrition
support team is based on expert opinion because there
isnopublisheddata.Involvinganutritionsupportteam’s
expertise can provide benefits, e.g. if it results in an in-
crease in efficacy of PN [1], [2], [3], [4], [5], [6], [7], [8],
[9], [10], [11], [12], [13], [14], [15].
Preparation of PN solutions
• “All-in-One” bags are generally preferred for PN in
hospitals (B).
• “All-in-One” bags may be industrially manufactured,
industrially manufactured with the necessity to add
micronutrients, or be prepared “on-demand” within or
outside the hospital according to a standardised or
individualcomposition.Thereisnogeneralpreference
for any one of these three concepts (C). Industrially
manufactured multi-chamber bags may be more eco-
nomical than the preparation of a bag in hospital, if
one considers the added personnel cost for the later
choice (B).
• InhospitalsPNbagsshouldbepreparedatthehospital
pharmacyundersterileconditionsaccordingtoagreed
quality assurance guidelines (B).
• Additions of micronutrients or other components to
PNbagsmustbeperformedunderasepticconditions,
and they should preferably be added under a Lamina
Airflow according to good manufacturing practice
(GMP) standards (C).
Commentary
Providing PN from multiple bottles should be avoided
because it is often more expensive than the multi-
chamber bag and it carries a higher risk for error [16],
[17].Thechoicebetweencommercialmulti-chamberbags
and individually prepared PN bags depends on the type
andstructuralconditionsofthehospitalaswellaspatient
needs. Individual PN compositions are usually preferred
for long-term and home PN, as well as for a number of
paediatric patients [18].
Prerequisites for preparing individually composed PN
solution include the need for a sterile workplace, regular
microbiological checks, and monitoring of compatibility
and stability [19], [20]. Further details are laid down in
guidelines of the Federal Chamber of Pharmacists [21].
In Germany PN solutions used in hospitals must be pre-
pared under the responsibility of a pharmacist [22].
Manufacture is defined in the German Drug Law: manu-
facture is the extraction, production, preparation, pro-
cessing, working, filling, packing and labelling of drugs
which includes PN [22]. Manufacturing permits, know-
how and authorisation with exceptions particularly re-
garding the pharmacy are regulated in the German Drug
Law. PN can only be manufactured in pharmacies and
without a special license. The preparation of nutrition
bags for immediate use (within no more than 24 h) may
be carried out by a physician or assistant staff.
The nutrition support team should advise the pharmacy
on the completion of its tasks, since otherwise recom-
mendations are not met to a satisfactory extent [23],
[24].
Sterility of PN bags aseptically prepared in the hospital
pharmacy may be guaranteed for up to 7 days at room
temperature [25]. However, this expert group recom-
mends that such solutions should be used within 24 h
afterpreparationifstoredatroomtemperature,orwithin
7 days if stored at 4°C. This recommendation is based
on the known risk of microbiological contamination and
physicochemicalchanges,whichareexpectedtoincrease
with storage time. Industrially-manufactured multi-
chamber bags can be stored for periods of months to
years as specified by the manufacturer. Attention should
be paid to the preparation of the multi-chamber bag for
use, since the stability of added components such as
vitamins is limited and often does not exceed 24 h at
room temperature [26].
In hospitals pumps should always be used for PN admin-
istration to ensure a controlled flow rate and to help
prevent metabolic and osmotic complications.
Advancement of enteral and oral
nutrition
• A standardised schedule should be established for
introduction and advancement of enteral or oral nutri-
tion (C).
• Individual advancement of enteral and oral nutrition
may be necessary in patients with gastroenterological
diseasessuchaspancreatitis,Crohn’sdisease,Colitis
Ulcerosa, hepatic cirrhosis, or after long-term PN for
more than 14 days (C).
• Theadvancementoforalnutritionresultsinaprogres-
sive supply of both macro- and micronutrients (C).
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Some studies have associated PN with altered morph-
ology and intestinal function, for example with reduced
mucosa thickness, a reduced number of villi in the small
intestineandincreasedintestinalpermeability[27],[28],
[29], [30], while other trials do not show such alterations
[31], [32]. If such effects occur, they depend on the dur-
ation of PN and are usually reversible.
In general a standardised advancement of enteral and
oral nutrition is recommended after PN, because clinical
practice has shown that incompatibilities may occur,
particularly in the adaptation phase, regardless of
whetherenteralororalnutrition.Astandardisedschedule
should be established for the advancement of enteral
and oral nutrition in the hospital. The speed of PN reduc-
tion depends on the tolerance of enteral or oral nutrition.
Based on expert opinion, nutrition consultation during
thephaseofadvancingenteralandoralnutritionisuseful,
particularly in patients who received PN for more than
14daysandinpatientswithgastroenterologicaldisease.
Advancement of enteral and oral nutrition must be
adaptedtothepatient’stolerance,particularlyinpancrea-
titis, where nutrition-related pain is well documented.
Consideration should also be dedicated to the type and
amount of protein given to patients with liver cirrhotic
patientsandimminentencephalopathy.Smallmealsand
theuseofmediumchaintriglyceridesmaybeusefulafter
gastrointestinal operations and in patients with dumping
syndrome.
Supplying PN
Standardisation of procedures
• Standardisation of procedures for supplying PN is re-
commendedtoensurequalityandtoreducecomplica-
tions (B).
Commentary
Standardisation includes a clear process for defining PN
indications, which is provided by the attending physician
and preferably checked by a nutrition support team (or
a physician dedicated to nutrition support). PN is only in-
dicated when sufficient oral or enteral nutrition is not
achievable. Criteria for the choice of central venous
catheters (individual or tunnelled catheters or PORT sys-
tems) should be laid down. The choice of macro- and
micronutrient intakes depends on energy requirements,
the patient’s metabolic situation, illness and other as-
pectsoftherapeuticstrategies.Energyrequirementscan
be estimated with the help of established formulas (i.e.
Harris-Benedict formula). A limited number of products
should be selected for PN, which can be decided on by
the nutrition support team jointly with the drugs commit-
tee and the hospital pharmacy. If individually prescribed
PN solutions are considered necessary the attending
physician and the nutrition support team, these should
be prepared by trained personnel under the guidance of
a pharmacist following standardised procedures under
sterile conditions. The application of PN must be moni-
tored and documented, for example by the nutrition
support team. The roles of the nutrition support team
contributegreatlytoestablishingstandardisedimplemen-
tation of PN, because the team is involved in most steps
and hence can take over main coordination tasks. Docu-
mented reductions of medical complications and of un-
necessarycostsbyinadequatePNarearguablytheresult
of the work of nutrition support teams [33], [34], [35],
[36], [37], [38].
Cost aspects of PN
• The adequate calculation of PN costs in hospital re-
quires internal accounting (C). Home PN is usually
available on prescription and is financed by health in-
surance funds, although additional payments by the
patient may be necessary.
Commentary
Hospital accounting is needed to secure funding for
central hospital services such as PN services [39], [40],
[41], and the multidisciplinary nutrition support team
jointly with the hospital pharmacy should aim at being
involved in the evaluation of cost aspects of PN. The nu-
trition support team should be funded by the health care
fundsandnotbyindustrialsponsorshiptoavoidpotential
conflicts of interests.
Home PN
• Home PN is a well established method for providing
long-term PN (A).
• Home PN is indicated if
(I) the patient cannot obtain adequate oral or enteral
feeding
(II) there are no other reasons for not discharging the
patient from hospital,
(III) home PN is expected to last for a period of at least
4 weeks,
(IV) the patient requests or is (presumably) in agree-
ment with home PN, and
(V) it is expected that disease state or quality of life
remains stable or is improved with home PN (C).
• The attending physician should decide on the indica-
tion for home PN, which should also be reviewed by
the nutrition support team (B).
• The patient or its legal representative should receive
extensive information on home PN and the need for
providingasuitablecathetersystem(tunnelledcentral
venous catheter or PORT). The nutrition support team
should be involved in all aspects of comprehensive
planning and organisation of home PN
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tions(i.e.cathetercomplications,metaboliccomplica-
tions, organisational deficiencies) and success rate
(i.e. improvement in nutritional status and quality of
life);andthenutrientsupplymustbeadaptedifneces-
sary,whichcanbedoneeitherbyadedicatednutrition
support team or by an outpatient physician experi-
enced in this area. The care of home PN patients
should be standardised whenever possible. The indi-
cationforhomePNshouldberegularlyreviewedduring
the course of PN.
Commentary
Complication rates during home PN are generally low.
Themostfrequentlyoccurringcomplicationsarecatheter
sepsis (0.34 occurrences per year), catheter occlusions
(0.071/year), catheter-associated central venous
thromboses (0.027/year), fluid and electrolyte disturb-
ances (0.12–0.61/year), liver and bile duct problems
(0.42/year) and other metabolic complications (os-
teopeny,hyperglycaemia,hypertriglyceridemiaetc.)[42],
[43], [44]. According to a European study, catheter com-
plications occur in approx. 0.25% of patients over the
course of home PN, 50% of these complications being
infections (equals 0.37/year) [45]. Comparable results
have been reported for children [46]. Validated methods
for reducing complications such as catheter infections
or thrombosis have not been reported [42]. For patients
with short bowel syndrome or other forms of intestinal
failure, the only alternative to long term PN is intestinal
transplantation, which is still associated with high rates
of complication despite impressive progress in this area
[47].
HomePNiscarriedoutintumourpatientswithperitoneal
carcinosisor (sub)ileus, inpatients with intestinalfailure,
such as short bowel due to Crohn’s disease, after intes-
tinal ischaemia with short gut infarction (e.g. superior
mesenteric artery or venous thromboses), radioenteritis
and in severe colonic motility disorders [42]. Tumour pa-
tients receiving home PN contribute a smaller number to
the home PN population in some other countries (e.g.
Denmark, UK) [48].
Many of the underlying principles for supplying PN also
applytohomePNanddependongeneralororgan-related
considerations(seeappropriatechapters).Someaddition-
al aspects must be considered with home PN. For ex-
ample, it is important to estimation the patient’s prog-
nosis and possible duration of home PN. Although there
is no scientifically agreed lower limit of duration, a min-
imal duration of home PN of at least one month is con-
sistently recommended. In adult patients the duration of
home PN is usually shorter than one year, because pa-
tientseitherdie(99%oftumourpatients)ororalorenter-
al nutrition can be established [49], [50]. There is expert
consensus that patients bound to die usually benefit do
notfrom(home)PN,whichshouldbecheckedevenmore
critically in the case of home PN than in hospital where
thereisusuallyadefinedtherapyobjective.Thisquestion
is difficult since definitions are imprecise and decisions
often need to be taken on an individual basis, taking into
accountthe(presumed)wishesofthepatientandeffects
on quality of life, which should be given high priority.
Home PN can positively influence in tumour patients if
patientssurviveatleastthreemonthsaftercommencing
homePN[51].However,qualityoflifeofpatientsonhome
PN was lower than in patients without home PN, which
may in part be due to a more severe underlying illness in
patients who require home PN [52], [53]. The quality of
lifeaftersmallintestinaltransplantsiscomparablyhigher
in patients without rejection [54], [55].
Which catheter system is optimal for home PN remains
controversial. Based on comparative studies we assume
that tunnelled central venous catheter (i.e. Broviac
®
catheter) may present slight advantages over port sys-
tems with respect to infections and catheter sepsis [45],
[56].Conventionalnon-tunnelledcentralvenouscatheters
should not be used outside the hospital [57]. The costs
and particularly the long-term costs of consumables are
significantlylowerwiththeuseofBroviac
®-cathetersthan
with implanted port systems, which require special
needlesforinjection.Individualfactorssuchasdailyinfu-
sionsorinfusionswithlargertimeintervalsandcosmetic
aspects should also to be considered selecting access
catheters. Hence, the choice of catheter is influenced by
many factors which have not been fully explored in com-
parative studies.
Preparation and organisation of Home PN is usually car-
ried out prior to patient discharge from hospital and re-
quires approx. 2–3 working days by the nutrition support
team and other hospital departments. Tasks include:
(I) review of indication,
(II) detailed information, clarification and consent of
patient and their relatives,
(III) preparation of individual composition,
(IV)authorisationofaqualifiedpharmacy,oraspecial-
ised home care company, for preparation of PN solu-
tions, home delivery of the materials, and implemen-
tation of home PN, potentially in collaboration with a
home care nursing service,
(V)individualinstructionofthepatientanditsrelatives
– depending on the wishes and degree of independ-
ence of the patient – by the nutrition support team or
the home care service organisation.
(VI) setting up a plan for monitoring, which may by
implemented by a general practitioner and/or a spe-
cialised clinic.
Thesestandardshavegenerallybeendevelopedempiric-
ally, but have also been tried-and-tested in various prac-
tical settings [33], [58], [59]. There is no standard
strategy to document complications and monitor home
PN. We recommend controls of clinical and laboratory
parameters every one to two weeks in the first three
months, followed by monthly checks over the next three
months, as recommended also in the Mayo Clinic
schedule (cf. chapter “Complications and monitoring”
http://www.egms.de/en/gms/2009-7/000076.shtml).
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extremely important in Home PN, because the bags are
often delivered only once a week or so to the patient and
then are stored in the refrigerator at 4°C until utilised
after hours of being warmed up to room temperature.
The micronutrients (vitamins, trace elements) show a
particularly limited storage time and should be added
just prior to using the PN bag [60]. The electrolyte and
mineralconcentrationsshouldbetakenintoconsideration
in bags containing lipids, because they may result in the
emulsion breaking (i.e. a separation of lipid and water
components) (cf. chapter “Practical handling of AIO ad-
mixtures”http://www.egms.de/en/gms/2009-7/000077.
shtml) [61]. The stability should be checked with the
manufacturer whenever the composition is modified.
The administration of home PN should be employed by
specially trained carers, or in individual cases by the pa-
tient, if the patient requests this and has been appropri-
ately trained [59]. It is important that measures associ-
ated with home PN are standardised by means of a suit-
able standard of care. The contents of these standards
of care are usually established by empirical measures
rather than hard scientific data, but they have been tried
andtestedandshouldformthebasisofstandardoperat-
ing procedures until scientifically accountable guidance
is available.
In conclusion, home PN is an area for which many
standards have been established, but which have rarely
been backed up by controlled, randomised trials. Thus,
there is a great need for studies in this area which might
contribute to improved quality of care and reducing the
burdening of in-patient departments.
Notes
This article is part of the publication of the Guidelines on
Parenteral Nutrition from the German Society for Nutri-
tional Medicine (overview and corresponding address
under http://www.egms.de/en/gms/2009-7/000086.
shtml).
English version edited by Sabine Verwied-Jorky, Rashmi
Mittal and Berthold Koletzko, Univ. of Munich Medical
Centre, Munich, Germany.
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